Tata Capital

At a recent analyst meeting, Tata Capital expressed confidence that its AUM would grow 23-25%, supported by healthy demand in retail and SMEs, which together account for 85-87% of its portfolio and are expected to gain further share.

Tata Capital Healthcare Fund aims to exit over half of its portfolio companies from its new ₹2,500 crore fund via IPOs, pivoting away from traditional strategic sales. The firm is raising ticket sizes while targeting growth drivers like medical devices, and single-specialty chains.

Shares of Bajaj Finance, Tata Capital and Cholamandalam Investment fall 5.8%, 3.2% and 3.8%, respectively, on the NSE.

Tata Capital has hit a record high after reiterating its FY28 growth roadmap. But with much of the optimism already priced in, investors may need to temper expectations.

Tata Capital-backed Anderson Diagnostics has launched a ₹250 crore fundraising process as India’s fast-growing diagnostics market attracts fresh investor interest.

The one-off boost from Tata Capital's listing comes even as Tata Trusts Chairman Noel Tata raises concern over mounting losses in Tata Digital to Air India.